Inovio Pharmaceuticals, Inc. (INO)
1.16
-0.05
(-4.13%)
USD |
NASDAQ |
Oct 02, 16:00
1.18
+0.02
(+1.72%)
After-Hours: 20:00
Inovio Pharmaceuticals Price to Book Value : 21.85 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 21.85 |
| October 01, 2026 | 22.80 |
| September 30, 2026 | 22.98 |
| September 29, 2026 | 20.91 |
| September 28, 2026 | 22.04 |
| September 25, 2026 | 22.23 |
| September 24, 2026 | 22.80 |
| September 23, 2026 | 23.55 |
| September 22, 2026 | 24.30 |
| September 21, 2026 | 23.36 |
| September 18, 2026 | 23.36 |
| September 17, 2026 | 22.80 |
| September 16, 2026 | 21.67 |
| September 15, 2026 | 21.85 |
| September 14, 2026 | 22.23 |
| September 11, 2026 | 23.55 |
| September 10, 2026 | 24.11 |
| September 09, 2026 | 24.87 |
| September 08, 2026 | 26.75 |
| September 04, 2026 | 26.94 |
| September 03, 2026 | 25.62 |
| September 02, 2026 | 25.62 |
| September 01, 2026 | 25.06 |
| August 31, 2026 | 23.93 |
| August 28, 2026 | 24.30 |
| Date | Value |
|---|---|
| August 27, 2026 | 23.74 |
| August 26, 2026 | 24.49 |
| August 25, 2026 | 24.30 |
| August 24, 2026 | 23.55 |
| August 21, 2026 | 22.23 |
| August 20, 2026 | 22.80 |
| August 19, 2026 | 24.49 |
| August 18, 2026 | 22.61 |
| August 17, 2026 | 21.67 |
| August 14, 2026 | 20.54 |
| August 13, 2026 | 16.96 |
| August 12, 2026 | 14.51 |
| August 11, 2026 | 14.43 |
| August 10, 2026 | 13.87 |
| August 07, 2026 | 12.58 |
| August 06, 2026 | 12.69 |
| August 05, 2026 | 12.75 |
| August 04, 2026 | 12.49 |
| August 03, 2026 | 13.13 |
| July 31, 2026 | 12.75 |
| July 30, 2026 | 12.36 |
| July 29, 2026 | 19.59 |
| July 28, 2026 | 19.40 |
| July 27, 2026 | 18.18 |
| July 24, 2026 | 18.28 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Nektar Therapeutics | 1.647 |
| Ironwood Pharmaceuticals, Inc. | -- |
| Fortress Biotech, Inc. | 0.412 |
| Tonix Pharmaceuticals Holding Corp. | 0.6731 |
| Kura Oncology, Inc. | 19.56 |
Price to Book Value Related Metrics
| Price | 1.16 |
| Earnings Yield | -101.4% |
| Market Cap | 95.52M |